Ceva’s New Bovine Anti-infective Provides Two Products In One Bottle

Ceva Animal health has introduced Marbox®, a broad-spectrum anti-infective, based on marbofloxacin, for the rapid treatment of bovine mastitis and respiratory disorders. Marbox® effectively provides two products in one bottle because it can be used as a high dose single injection or administered at a lower dose over several days. Mastitis and respiratory disorders currently account for around 60% of antimicrobial prescriptions. Marbox® can be used intramuscularly as a single injection for the treatment of respiratory infection. Alternatively it can be used for the treatment of acute mastitis; intravenously for the first injection and then subcutaneously at a lower dose over three days. It has a milk withdrawal of just 36 hours after subcutaneous injection. Marbox® is presented in an ergonomic CLAS vial which makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. It is available in 100 and 250 vial sizes and contains 100mg marbofloxacin per ml. Marbox® can be used in combination with Meloxidyl®, Ceva’s new, single shot anti-inflammatory. The product joins Ceva’s popular bovine range of anti-infectives, which includes Cevaxel®, Florkem® and Spectam® Injectable. For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards